“2023 JP Morgan, large-scale M&A missing… Big Pharma seeks to respond to patent expiration”
At the 2023 JP Morgan Healthcare Conference, there is no news of large-scale M&A (mergers and acquisitions) compared to previous years, and global big pharmas are expected to introduce new products and promising pipelines in preparation for patent expiration. According to Kiwoom Securities’ ‘JP Morgan Healthcare Conference Summary’ report, this JP Morgan Healthcare Conference, which … Read more